Ti L, Tobias S, Maghsoudi N, Milloy MJ, McDonald K, Shapiro A, Beriault D, Stefan C, Lysyshyn M, Werb D Detection of synthetic cannabinoid adulteration in the unregulated drug supply in three Canadian settings Drug Alcohol Rev, 2021. PubMed

Mackay L, Kerr T, Fairbairn N, Grant C, Milloy MJ, Hayashi K The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting Addict Sci Clin Pract, 2021. PubMed

Brooks O, Bach P, Hayashi K Considering rationales for use in defining subgroups for the treatment of stimulant use disorder Drug Alcohol Depend, 2021. PubMed

Meyers SA, Rafful C, Mittal ML, Smith LR, Tirado-Muñoz J, Jain S, Sun X, Garfein RS, Strathdee SA, DeBeck K, Hayashi K, McNeil R, Milloy MJ, Olding M, Guise A, Werb D, Scheim AI Examining the gender composition of drug injecting initiation events: a mixed methods investigation of three North American contexts Int J Drug Policy, 2021. PubMed

Moallef S, Hayashi K The effectiveness of drug-related Good Samaritan laws: a review of the literature Int J Drug Policy, 2021. PubMed

Olding M, Barker A, McNeil R, Boyd J Essential work, precarious labour: the need for safer and equitable harm reduction work in the era of COVID-19 Int J Drug Policy, 2021. PubMed

Goodyear T, Lowik AJ, Robinson S, Knight R Re: "Disparities in prescription opioid misuse affecting sexual minority adults are attenuated by depression and suicidal ideation" by Morgan et al LGBT Health, 2021. PubMed

Socías ME, Choi J, Lake S, Wood E, Valleriani J, Hayashi K, Kerr T, Milloy MJ Corrigendum to 'Cannabis use is associated with reduced risk of exposure to fentanyl among people on opioid agonist therapy during a community-wide overdose crisis' [Drug Alcohol Depend. 219 (2021) 108420] Drug Alcohol Depend, 2021. PubMed

Voon P, Wang L, Nosova E, Hayashi K, Milloy MJ, Wood E, Kerr T Pain and barriers to accessing health services among people who use drugs Pain Manag Nurs, 2021. PubMed

Brar R, Fairbairn N, Colizza K, Ryan A, Nolan S Hospital initiated injectable opioid agonist therapy for the treatment of severe opioid use disorder: a case series J Addict Med, 2021. PubMed